In resistant HCC models, PERK/ATF4-dependent ZFAS1 upregulation correlates with ER stress activation, while pharmacological PERK inhibition restores drug sensitivity by suppressing ZFAS1 expression [90] (Fig. 3A). Here, EIF2AK3 is linked to hepatocellular carcinoma.